The purpose of this study is to evaluate a patient-centered diabetes self-management mobile application (app), which was developed with feedback from both patients and healthcare providers. During the 12 month randomized control trial, participants in the intervention group will be provided with a mobile phone and commercial home medical devices, such as a weight scale, glucometer and activity monitor. The measurements taken from the medical devices will wirelessly transfer to the mobile phone, where the app will assess the data and provide patients with actionable self-management knowledge. The proposed intervention may be helpful in increasing adherence to recommended self-care practices, improving self-efficacy, and enhancing the overall patient experience.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
23
Mount Sinai Hospital
Toronto, Ontario, Canada
Change in HbA1c from baseline to 12 months
Time frame: Baseline, 3, 6, 9 and 12 months
Blood pressure
Time frame: Baseline, 3, 6, 9 and 12 months
Weight
Time frame: Baseline, 3, 6, 9 and 12 months
Cholesterol (LDL and total)
Time frame: Baseline, 6 and 12 months
Medication changes
Time frame: 3, 6, 9 and 12 months
Glycemic excursions
Time frame: 3, 6, 9 and 12 months
BMI
Time frame: Baseline, 3, 6, 9 and 12 months
Diabetes Distress Scale
Time frame: Baseline, 6 and 12 months
Diabetes Empowerment Scale
Time frame: Baseline, 6 and 12 months
Summary of Diabetes Self-Care Activities
Time frame: Baseline, 6 and 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.